Feed AGNPF
AG

Grey Matters Health Inc.

AGNPF · OTC

$0.37 +0.00% (+$0.00)
1M +13.49%
Market Cap $2.78M
P/E Ratio -
Div. Yield -
ROE 104.94%

Bulios Fair Price

$0.4

8.3% upside

Current Price

$0.37

Undervalued Fair Value Overvalued

According to Bulios Fair Price, AGNPF is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
2/9
Valuation
98 /100
Cheap
P/B 1.59x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining
Book val. growth 21.77%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A
Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor
ROIC 80.51%
ROE 104.94%
ROA 46.63%
Debt
41 /100
Moderate
Debt/Equity 0.44x
Current ratio 0.13x
Int. coverage -130.66x
Stability
9 /100
Unstable
Beta 0.29x
EPS volatility 119.58%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AGNPF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Christopher J. Moreau

Employees

5

Headquarters

Vancouver

Upcoming events

18 DEC

Earnings

Upcoming earnings report

94d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.